Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Published in: Annals of Hematology 4/2019

01-04-2019 | Letter to the Editor

Anti-glomerular basement membrane disease due to monoclonal IgG Lambda antibodies: a very rare case of monoclonal gammopathy of renal significance

Authors: C. Peña, R. Valjalo, X. Rocca, M. Roa, A. Morales, G. P. Méndez

Published in: Annals of Hematology | Issue 4/2019

Login to get access

Excerpt

Dear Editor, …
Literature
1.
Leung N, Bridoux F, Hutchison CA, Nasr SH, Cockwell P, Fermand JP, Dispenzieri A, Song KW, Kyle RA (2012) International kidney and monoclonal gammopathy research group. Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificant. Blood 120:4292–4295CrossRefPubMed
2.
Coley SM, Shirazian S, Radhakrishnan J, D’Agati VD (2015) Monoclonal IgG1κ anti-glomerular basement membrane disease: a case report. Am J Kidney Dis 65:322–326CrossRefPubMed
3.
Vankalakunti M, Nada R, Kumar A, Patro K, Ramakrishnan S, Rangarajan D (2017) Circulating monoclonal IgG1-kappa antibodies causing anti-glomerular basement membrane nephritis. Indian J Nephrol 27:327–329CrossRefPubMedPubMedCentral
4.
Fervenza FC, Terreros D, Boutaud A, Hudson BG, Williams RA Jr, Donadio JV Jr, Schwab TR (1999) Recurrent Goodpasture’s disease due to a monoclonal IgA-kappa circulating antibody. Am J Kidney Dis 34:549–555CrossRefPubMed
5.
Savige JA, Yeung SP, Bierre AR, Kincaid-Smith P (1989) Lambda-light-chain-mediated anti-GBM disease. Nephron 52:144–148CrossRefPubMed
6.
Nasr SH, Collins AB, Alexander MP, Schraith DF, Herrera Hernandez L, Fidler ME, Sethi S, Leung N, Fervenza FC, Cornell LD (2016) The clinicopathologic characteristics and outcome of atypical anti-glomerular basement membrane nephritis. Kidney Int 89:897–908CrossRefPubMed
Metadata
Title
Anti-glomerular basement membrane disease due to monoclonal IgG Lambda antibodies: a very rare case of monoclonal gammopathy of renal significance
Authors
C. Peña
R. Valjalo
X. Rocca
M. Roa
A. Morales
G. P. Méndez
Publication date
01-04-2019
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 4/2019
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-018-3513-4

Other articles of this Issue 4/2019

Annals of Hematology 4/2019 Go to the issue

Original Article

Role of platelets in thrombin generation amongst patients with non-transfusion-dependent thalassaemia

Original Article

Inhaled steroids associated with decreased macrophage markers in nonasthmatic individuals with sickle cell disease in a randomized trial

Original Article

Treatment patterns and comparative analysis of non-intensive regimens in elderly acute myeloid leukemia patients—a real-world experience from India

Original Article

Clinical characteristics and prognosis of immunoglobulin D myeloma in the novel agent era

Original Article

Incidence, risk factors, and clinical significance of Epstein–Barr virus reactivation in myelodysplastic syndrome after allogeneic haematopoietic stem cell transplantation

Original Article

Next-generation sequencing with a 54-gene panel identified unique mutational profile and prognostic markers in Chinese patients with myelofibrosis
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits